Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis. [PDF]
Wang Q +13 more
europepmc +1 more source
ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients
Type 2 diabetes mellitus (T2DM) is a globally prevalent metabolic disorder, and cardiovascular disease (CVD) is a significant cause of mortality and morbidity in diabetic individuals. In addition to hyperglycemia, lipid abnormalities associated with T2DM
Jingfei Chen +6 more
doaj +1 more source
Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study. [PDF]
Hussain A +7 more
europepmc +1 more source
Blocking ANGPTL3 and CD47 impact on atherosclerosis-correspondence
Han-Yong Hou +4 more
doaj +1 more source
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome. [PDF]
Karaca ÖA +4 more
europepmc +1 more source
Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome. [PDF]
Tanaka H +9 more
europepmc +1 more source
The Clinical Role of Angiopoietin-Like Protein 3 in Evaluating Coronary Artery Disease in Patients with Obstructive Sleep Apnea. [PDF]
Li J +8 more
europepmc +1 more source
Circulating Angiopoietin-Like Protein 3 Level and Plaque Calcification: An Optical Coherence Tomography Imaging Analysis. [PDF]
Kataoka Y +14 more
europepmc +1 more source
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial. [PDF]
Gaudet D +12 more
europepmc +1 more source
Unveiling the PGAM5-ANGPTL3 Axis
Eva Hurt-Camejo, PhD
doaj +1 more source

